151 related articles for article (PubMed ID: 33803038)
1. O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice.
Kang S; Lee AY; Park SY; Liu KH; Im DS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803038
[TBL] [Abstract][Full Text] [Related]
2. The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis.
Fondevila MF; Fernandez U; Gonzalez-Rellan MJ; Da Silva Lima N; Buque X; Gonzalez-Rodriguez A; Alonso C; Iruarrizaga-Lejarreta M; Delgado TC; Varela-Rey M; Senra A; Garcia-Outeiral V; Novoa E; Iglesias C; Porteiro B; Beiroa D; Folgueira C; Tojo M; Torres JL; Hernández-Cosido L; Blanco Ó; Arab JP; Barrera F; Guallar D; Fidalgo M; López M; Dieguez C; Marcos M; Martinez-Chantar ML; Arrese M; Garcia-Monzon C; Mato JM; Aspichueta P; Nogueiras R
Hepatology; 2021 Feb; 73(2):606-624. PubMed ID: 32329085
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
4. 7
Huang J; Lee SJ; Kang S; Choi MH; Im DS
J Pharmacol Exp Ther; 2020 Jul; 374(1):142-150. PubMed ID: 32341017
[TBL] [Abstract][Full Text] [Related]
5. GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression.
Lee SJ; Im DS
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884889
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
7. Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis.
Tao XR; Rong JB; Lu HS; Daugherty A; Shi P; Ke CL; Zhang ZC; Xu YC; Wang JA
J Lipid Res; 2019 Dec; 60(12):1983-1995. PubMed ID: 31604805
[TBL] [Abstract][Full Text] [Related]
8. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
[TBL] [Abstract][Full Text] [Related]
10. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner.
Zhang X; Zhan Y; Lin W; Zhao F; Guo C; Chen Y; Du M; Li D; Zhang L; An W; Wang HR; Xie P
FASEB J; 2020 Jun; 34(6):7631-7643. PubMed ID: 32301540
[TBL] [Abstract][Full Text] [Related]
11. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal.
Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW
Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990
[TBL] [Abstract][Full Text] [Related]
12. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
13.
Park M; Yoo JH; Lee YS; Lee HJ
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30813654
[TBL] [Abstract][Full Text] [Related]
14. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
[TBL] [Abstract][Full Text] [Related]
15. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
[TBL] [Abstract][Full Text] [Related]
16. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
17. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
19. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
[TBL] [Abstract][Full Text] [Related]
20. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.
Lee MR; Park KI; Ma JY
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
